Revisiting the benefits of isovolemic hemodilution red cell exchange for sickle cell disease.
Manasa S ReddyAhmad M AlkashashAndrew NordAnne TetrickPublished in: Journal of clinical apheresis (2023)
Our data do not support the observation of both IHD-RCE benefits, decreased red cell usage per exchange and lower FCR/increased interprocedure interval, simultaneously.